丸美生物(603983.SH)筹划发行H股股票并申请在香港联交所上市

Group 1 - The core point of the article is that Marubi Biotechnology (603983.SH) plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its capital strength and overseas financing capabilities [1] - The company aims to improve its overall competitiveness and accelerate its internationalization strategy as part of its overall development strategy and operational needs [1]